Greg Lovins
Analyst · BofA Securities. Please go ahead
Thanks, Mitch, and hello everybody. Though this past quarter was one of the most challenging ever for the company, we are executing extremely well. We delivered adjusted earnings per share of $1.27 for the quarter, which was better than our expectations, as the pandemic driven decline in sales was not as severe as our April outlook assumed. Specifically, sales declined by 12% ex currency or 13.7% on an organic basis. And currency translation reduced reported sales by 2.9 points in the quarter. As Mitch noted, despite the drop in revenue, we reported an adjusted EBITDA margin of 14%, down 60 basis points and an adjusted operating margin of 10.7%, down 140 basis points. And we realized $15 million of net restructuring savings in the quarter with close to half of that representing carryover from prior year projects. And we recorded approximately $39 million of restructuring charges. These charges relate to the acceleration of actions that teams are taking this year in the businesses is most impacted by COVID-19. And we are now targeting between $60 million and $70 million of incremental net savings from restructuring this year, with roughly half of that in RBIS. We also delivered roughly $75 million in net temporary savings in the quarter, made up of belt tightening actions, such as travel reductions, reductions in overtime and temporary labor and furloughs, as well as lower incentive compensation accruals. Turning to cash generation and allocation. Year-to-date, we realized $109 million of free cash flow with $144 million generated in the second quarter. And we expect free cash flow to accelerate in the second half, reflecting normal seasonality, as well as higher net income and a continued focus on working capital productivity. With regard to the latter, our main focus this year has been the management of receivables. And collections in the quarter were in line with our expectations. We are also now turning our attention to reducing inventory levels, which have ticked up, reflecting the timing of sales at the end of the quarter, some strategic sourcing decisions, as well as a little less focus given other priorities in the quarter. We expect inventory ratios to be back in line with our normal levels in the second half. Our balance sheet remains strong with a net debt to adjusted EBITDA ratio at quarter end of 2.1, below our long term target range of 2.3 to 2.6. And we have ample liquidity with $800 million available under our revolving credit facility and more than $250 million in cash at quarter end. And you may recall that we have drawn $500 million from our revolver back in March in light of the uncertainty of commercial paper markets at the time. In June, as it became clear that CP markets have stabilized, we repaid those loans. As you know, our long term priorities for capital allocation support our primary objectives of delivering faster growth in high value categories, alongside profitable growth of our base businesses. These priorities are unchanged in the current environment. In particular, we continued to protect our investments in high value categories, while curtailing our original capital spending plans for the year by approximately $55 million in the other areas of the business. And as noted last quarter, we are maintaining our dividend rate during this period of uncertain global demand. And we've not yet resumed share repurchase activity, following our decision in March to pause this program as the crisis unfolded. Turning to segment results for the quarter. Label and graphic material sales were down 4.9% on an organic basis, driven largely by volume and mix. Sales were unchanged organically in label and packaging materials, as modest growth in the base label and specialty labeled categories was offset by mid teens decline for durable label categories, reflecting the general slowdown in durable goods production. Looking at LPM’s organic sales trends by month and region. North America and Europe went from low double digit growth in a combined March and April to high single digit growth in May and then declined in June as Mitch indicated earlier. The trend in China was a bit choppy with a low single digit decline overall for the quarter. And South Asia saw mid-teen declines in both April or May, reflecting the widespread closures, particularly in India, with a significant sequential improvement in June, which came in nearly even with prior year. And finally, results in Latin America were down low single-digits overall for the quarter. As Mitch mentioned, in the combined graphics and reflective solutions business, sales declined by approximately 30% organically but improved through the quarter. LGM's adjusted operating margin increased 100 basis points to 14.8% as the benefits of productivity, including material re-engineering and net restructuring savings, as well as raw material deflation net of pricing, more than offset unfavorable volume and mix. And shifting now to retail branding and information solutions. RBS sales were down 28% ex currency and 36% on an organic basis, reflecting an approximately 40% decline in the base business, driven by site closures and lower apparel demand. As Mitch noted, ex currency enterprise-wide RFID sales were up more than 10%, driven by the Smartrac acquisition and down 20% on an organic basis. And note that, while LGM represents a separate and distinct channel of access to printers and converters purchasing our RFID inlays, for simplicity during the integration, in the second quarter, we decided to recognize the results associated with the Smartrac acquisition solely in RBIS. Overall, results in RBIS reflect strong sequential improvement in demand every month since April. Looking at the base apparel business, the value channel held up best for the quarter though still down close to 30% on an organic basis, while premium fashion deteriorated the most. Adjusted operating margin for the segment declined to roughly 1%, reflecting reduced fixed cost leverage in this high-variable margin business, which was partially offset by aggressive cost control measures. Turning to the industrial and healthcare materials segment. Sales fell 21% on an organic basis, reflecting an approximate 30% decline in industrial categories, driven by automotive. Adjusted operating margin decreased 370 basis points to 6.8% due to reduced fixed cost leverage, partially offset by productivity. And now shifting to our outlook. Given the uncertainty regarding global demand, we're not resuming annual guidance at this time. As we did in March and June, we will arrange an Update Call in September to let you know how things are playing out. In the meantime, I'll highlight some of the key pieces of the equation that we have reasonable visibility to now. We expect in our third quarter sales will be down 5% to 7% on an ex currency basis and 7% to 9% organically. So far in July, total company sales ex currency are down about 5% or roughly 7% on an organic basis with LGM down about 6%, RBIS down about 5% and IHM down about 14%. Our organic sales outlook for the third quarter assumes that LGM will be down mid single-digits, RBIS will slow down relative to July and be down mid teens and IHM will show a modest sequential improvement compared to July. As mentioned, we also expect to generate restructuring savings net of transition costs of $60 million to $70 million this year, up $10 million from our view in April, and we're targeting roughly $150 million of net temporary savings, which is noted includes reductions in accruals related to incentive plans. And note that over half of the full year total for temporary savings has been realized in the first half of the year, with much of that in the second quarter. And keep in mind, the vast majority of the temporary actions we are taking are expected to be a headwind for us when markets recover. As Mitch said, protecting our margins is a key focus for us during this period of slower growth. Assuming we continue to see sequential improvement in demand trends through the second half, we are targeting to deliver an adjusted EBITDA margin for the full year in line with prior year. And finally, we are targeting to generate roughly $500 million of free cash flow this year, roughly comparable to what we delivered last year, with our target including an increase in cash restructuring costs associated with new initiatives and a higher cash tax rate related to repatriation of foreign earnings. Our free cash flow target includes an expected $165 million to $175 million of spending on fixed and IT investments, and another roughly $60 million in cash payments associated with restructuring actions. In summary, we are very well positioned to navigate this challenging environment and we look forward to coming out even stronger when our markets recover. And now we'll open up the call for your questions.